Researchers showed that strawberry extract can inhibit the spread of laboratory-grown breast cancer cells, even when they are inoculated in female mice to induce tumours.
Past studies have shown that the ingestion of 500 grammes of strawberries (between 10 and 15 strawberries) per day offers antioxidant and anti-inflammatory benefits and reduces blood cholesterol levels.
The new study presents promising results on the potential positive effects of the fruit to prevent or treat breast cancer.
The in vitro model used cells from the highly aggressive, invasive A17 tumour cell line, these were treated with different concentrations (between 0.5 and 5 milligramme per millilitre) of extract of the Alba variety of strawberry, for periods of 24, 48 and 72 hours.
This decreased cell viability (dependent on dosage and time), blocked the cycle leading to cell division and inhibited migration, researchers said.
The extract simultaneously stimulated expression of the gene Htatip2, which is thought to suppress metastasis to the lymphatic ganglion in breast cancer patients, researchers said.
The in vivo model used female laboratory mice, which at one month of age were divided into two groups: one was given a standard diet, while the other group was given an enriched diet, 15 per cent of which was strawberry extract.
Another month later, all the mice were injected with A17 breast cancer cells.
"We also saw a significant reduction in the weight and volume of the tumour," Battino said.
"The majority of diseases, including cancer, are complex and involve complex interactions between cellular and molecular systems that determine the development of the disease," he said.
"These results are without a doubt valid for understanding potential effects of strawberries on breast cancer and the molecular mechanisms involved, but they must be complemented with clinical and epidemiological studies to verify whether humans experience the same positive effects as we have observed in mice," Battino said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
